Section A: General Information
All reagents were used as received from commercial sources without further purification or prepared as described in the literature. Reactions were stirred using Teflon-coated magnetic stirring bars. TLC plates were visualized by ultraviolet light or by treatment with a spray of Pancaldi reagent {(NH4) 6 MoO 4 , Ce(SO 4 ) 2 , H 2 SO 4 , H 2 O}. Chromatographic purification of products was carried out by flash column chromatography on silica gel (60-120mesh). Melting points were determined either on DSC-60A, Schimadzu or on an electrothermal melting point apparatus and are uncorrected. Infrared spectra were recorded on a Perkin-Elmer 1650 Fourier transform spectrometer. NMR spectra were measured in CDCl 3 , DMSO-d 6 (all with TMS as internal standard) on a Varian Gemini 400 MHz FT and 500 MHz FT magnetic resonance spectrometers. Chemical shifts ( ) are reported in ppm, and coupling constants (J) are in Hz. The following abbreviations were used to explain the multiplicities: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet. Mass spectra were recorded on an HP-5989A quadrapole mass spectrometer Section B: Experimental Procedures 1. Synthesis of 2-Oxo-N-phenethyl-2-phenylacetamide (7a): A mixture of 2,2-dibromo-1-phenylethanone (8a) (6.0 g, 21.6 mmol) and sodium iodide (6.48 g, 43.2 mmol) in sulfolane (30.0 mL) at 20-25 °C was stirred for 40-50 minutes. Powdered tripotassium phosphate (11.46 g, 54 mmol) and 2-phenyl ethylamine (9a) (3.15 g, 25.8 mol) were then added into the reaction mixture under nitrogen atmosphere and was stirred for about 2 hours at room temperature (30-35 °C). Tert-butyl hydroperoxide solution (5.5 M in decane, 4.89 mL, 27 mmol) was then added into the reaction mixture over a period of 5 minutes and reaction mixture was stirred for another 4-6 hours at room temperature. After completion of the reaction (by TLC), and usual organic extractive work up followed by column chromatographic purification, the expected 2-oxo-N-phenethyl-2-phenylacetamide (7a) was isolated in 50% yield (2.76 g).
2. Synthesis of (4-Methoxyphenyl)(5,6,7-trimethoxy-3,4-dihydroisoquinolin-1-yl)methanone (6d):
2-(4-Methoxyphenyl)-2-oxo-N-(2,3,4trimethoxy phenethyl)acetamide (7d) (1.62 g, 4.34 mmol) in POCl 3 (16 mL) was taken in the RB flask under nitrogen atmosphere and the mixture was heated at 80 °C for 12 h under N 2 . The mixture was then cooled to 0 °C and quenched into saturated sodium bicarbonate solution (160 ml) below 10°C. The product was then extracted with DCM (25 ml). The organic layer was washed with 10% sodium bicarbonate solution (25 ml) and dried over anhydrous sodium sulphate. The organic layer was distilled off under vacuum, added hexane (10 ml) and filtered the product to provide as pale yellow color solid (1.36 g, 88%); mp 143-145 °C.
1-Benzoyl Isoquinoline (5a):
To a stirred solution of 1-benzoyl dihydroisoquinoline (6a, 14) (1.15 g, 4.89 mmol) in DCM (12 mL) was added DBU (2.2 mL, 14.6 mmol) and the mixture was stirred at 25 °C for 12 hours. The mixture was concentrated in vacuo and the obtained residue was purified by column chromatography (silica gel, Pet.ether-EtOAc, 7:3) to give 5a as a light yellow color solid (0.91 g, 80%); mp 75-77 °C
Synthesis of (4-Methoxyphenyl)(5,6,7-trimethoxyisoquinolin-1-yl)methanone (3):
To a stirred solution of (4-methoxyphenyl)(5,6,7-trimethoxy-3,4-dihydroisoquinolin-1-yl)methanone (6d) (900 mg, 2.54 mmol) in DCM (9 mL) was added DBU (1.14 mL, 7.62 mmol) and the mixture was stirred at 25 °C for 12 h. The mixture was concentrated in vacuo and the obtained residue was purified by column chromatography (silicagel, Pet.ether-EtOAc, 7:3) to give 3 as a cream color solid (720 mg, 80%); mp 146-148 °C. 2-(4-methoxyphenyl)-2-oxo-N-(3,4,5-trimethoxyphenethyl) 11. (4-methoxyphenyl)(6,7,8-trimethoxy-3,4-dihydroisoquinolin-1-yl) 
N-(2-(benzo[d][1,3]dioxol-5-yl)ethyl)-2-(4-methoxyphenyl)-2-oxoacetamide (7c):
60.8, 107.3, 113.7, 124.3, 126.4, 133.7, 142.2, 151.9, 152.7, 162.4, 164.5, 185.8; MS: m/z (%) = 374.2 [M+1]. 5.
methanone (6e):
Pale 12. (3,4-dimethoxyphenyl)(6,7,8-trimethoxy-3,4-dihydroisoquinolin-1-yl) 
